Similar Search Results

The commercial contribution of clinical studies for pharmaceutical drugs

Sood, Ashish; Kappe, Eelco; Stremersch, Stefan - In: International journal of research in marketing : IJRM ; … 31 (2014) 1, pp. 65-77

Persistent link: https://www.econbiz.de/10010370705

Health-based pharmaceutical pay-for-performance risk-sharing agreements

Mahjoub, Reza; Odegaard, Fredrik; Zaric, Gregory S. - In: Journal of the Operational Research Society : OR 65 (2014) 4, pp. 588-604

Persistent link: https://www.econbiz.de/10010345220

In whom we trust : the role of certification agencies in online drug markets

Bate, Roger; Jin, Ginger Zhe; Mathur, Aparna - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 111-150

Persistent link: https://www.econbiz.de/10010345596

An empirical model of drug pricing and competition : a dynamic perspective

Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, F. F. H. - In: International journal of economics and business research 6 (2013) 2, pp. 173-193

Persistent link: https://www.econbiz.de/10010351165

Western European Markets for biosimilar and generic drugs : worth differentiating : Editorial

Garattini, Livio; Curto, Alessandro; Van de Vooren, … - In: The European journal of health economics : HEPAC ; … 16 (2015) 7, pp. 683-687

Persistent link: https://www.econbiz.de/10011482938

Re-thinking pharmaceutical production in Africa : insights from the analysis of the local manufacturing dynamics in Mozambique and Zimbabwe

Russo, Giuliano; Banda, Geoffrey - In: Studies in comparative international development 50 (2015) 2, pp. 258-281

Persistent link: https://www.econbiz.de/10011486482

Inbound open innovation for pharmaceutical markets : a case study of an anti-diabetic drug in-licensing decision

Wu, Allan Ya-Huan; Little, Victoria Janine; Low, Brian - In: The journal of business & industrial marketing 31 (2016) 2, pp. 205-218

Persistent link: https://www.econbiz.de/10011486501

Reconciling estimates of the value to firms of reduced regulatory delay in the marketing of their new drugs

Wilmoth, Daniel R. - In: Health economics 24 (2015) 12, pp. 1651-1656

Persistent link: https://www.econbiz.de/10011486883

The adoption of new prescription drugs is strongly associated with prior category prescribing rate

Stern, Philip; Wright, Malcom - In: International journal of research in marketing : IJRM ; … 33 (2016) 1, pp. 220-224

Persistent link: https://www.econbiz.de/10011490911

Hospitals and the generic versus brand-name prescription decision in the outpatient sector

Pruckner, Gerald J.; Schober, Thomas - 2016

Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show that there are strong interrelations in drug prescriptions between the inpatient and the outpatient sector using a large administrative dataset from Austria. Patients with prior hospital visits have a...

Persistent link: https://www.econbiz.de/10011519140